What SSRI (Selective Serotonin Reuptake Inhibitor) can be used to treat itching?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

SSRIs for Treatment of Pruritus

Sertraline is the most effective SSRI for treating pruritus, particularly in cholestatic and uremic itch, and should be considered as a third-line treatment option after first-line cholestyramine and second-line rifampicin. 1

Types of Pruritus Responsive to SSRIs

SSRIs work by increasing serotonin concentrations, which can modulate itch perception at both peripheral and central levels. The evidence supports their use in several types of pruritus:

  1. Cholestatic Pruritus

    • Sertraline (100 mg daily) is recommended as a third-line treatment 1
    • Has shown significant improvement in pruritus symptoms in patients with primary biliary cirrhosis 2
    • Effective in children with cholestatic pruritus at doses of 1-4 mg/kg/day 3
  2. Uremic Pruritus

    • Sertraline has demonstrated effectiveness in end-stage renal disease patients 4
    • Can significantly reduce the severity of pruritus in hemodialysis patients
  3. Polycythemia Vera-Associated Pruritus

    • SSRIs are recommended as a treatment option 1
    • Often used when other treatments like aspirin, cytoreductive therapy, or interferon-alpha are ineffective

Treatment Algorithm for Pruritus

  1. First-line treatments:

    • Cholestatic pruritus: Cholestyramine (4-16 g/day) 1
    • Uremic pruritus: Gabapentin or nalfurafine 5
    • Polycythemia vera: Aspirin 300 mg daily 1
  2. Second-line treatments:

    • Cholestatic pruritus: Rifampicin (300-600 mg/day) 1
    • Uremic pruritus: Naltrexone 5
    • Polycythemia vera: Interferon-alpha, UVB phototherapy 1
  3. Third-line treatments:

    • Sertraline (75-100 mg daily) for cholestatic pruritus 1
    • Paroxetine or fluvoxamine for neuropathic pruritus 1
    • Mirtazapine for generalized pruritus of unknown origin 1

Dosing and Administration

  • Sertraline: Start at 25-50 mg daily and titrate up to 75-100 mg daily as needed and tolerated
  • Paroxetine: Typically 20 mg daily
  • Fluvoxamine: Start at 50 mg daily, can increase to 100 mg daily

Monitoring and Side Effects

  • Monitor for common SSRI side effects: nausea, headache, insomnia, sexual dysfunction
  • Rare but important: Some patients may experience paradoxical worsening of pruritus with SSRIs 6
  • Elderly patients may be more sensitive to side effects and should start at lower doses
  • Drug interactions should be carefully considered, especially with other serotonergic medications

Special Considerations

  • Hepatic impairment: Use caution with sertraline in severe liver disease; may need dose reduction
  • Renal impairment: Generally safe but monitor closely
  • Pregnancy: Risk-benefit assessment needed; generally category C
  • Pediatric use: Sertraline has been used successfully in children with cholestatic pruritus at 1-4 mg/kg/day 3

Treatment Duration

  • Initial trial of 4-8 weeks to assess efficacy
  • If effective, treatment may be continued long-term as needed
  • Periodic attempts at dose reduction or discontinuation may be reasonable in patients with sustained improvement

Limitations and Caveats

  • Evidence for SSRI use in pruritus is primarily from small studies and case reports
  • Individual response may vary significantly
  • May take 2-4 weeks to see maximum benefit due to SSRI mechanism of action
  • Not FDA-approved specifically for pruritus treatment

SSRIs represent an important option in the treatment algorithm for pruritus, particularly for patients who have failed first- and second-line therapies. Sertraline has the strongest evidence base among the SSRIs for this indication.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Sertraline as an Additional Treatment for Cholestatic Pruritus in Children.

Journal of pediatric gastroenterology and nutrition, 2017

Research

Effect of sertraline on uremic pruritus improvement in ESRD patients.

International journal of nephrology, 2012

Research

An evidence-based review of systemic treatments for itch.

European journal of pain (London, England), 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.